Clinical Trials in Austin

Showing 1841-1860 of 13,060 trials

Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study

NCT06312722

The goal of this clinical trial is to verify the continued safety and effectiveness for the Optilume BPH Catheter System.

Benign Prostatic Hyperplasia

Urotronic Inc.92 participantsStarted Feb 2024

Little Rock, Arkansas, United States • Tampa, Florida, United States • Shreveport, Louisiana, United States +2 more locations

COMPLETEDPhase 317 miles

A Single Arm Study Evaluating the Efficacy, Safety and Tolerability of Ofatumumab in Patients With Relapsing Multiple Sclerosis

NCT04486716

A single arm study evaluating the continued efficacy, safety and tolerability of ofatumumab in patients with relapsing multiple sclerosis who are transitioning from aCD20 mAb therapy

Relapsing Multiple Sclerosis

Novartis Pharmaceuticals111 participantsStarted Oct 2020

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Pomona, California, United States +17 more locations

Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study

A Single Arm Study Evaluating the Efficacy, Safety and Tolerability of Ofatumumab in Patients With Relapsing Multiple Sclerosis

Find Trials by Condition in Austin

Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial

Study to Evaluate Neuromodulation Subject Experience With Contemporary Spinal Cord Stimulation (SCS) Modalities for Chronic Pain

Artificial Urinary Sphincter Clinical Outcomes

Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery

Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

A Safety, Tolerability and Pharmacokinetics Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)

Cerliponase Alfa Observational Study in the US

A Clinical Study of Intismeran Autogene (V940) Treatment and Pembrolizumab in People With Bladder Cancer (V940-005/INTerpath-005)

ALRN-6924 in Patients With Advanced Solid Tumors or Lymphomas

A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma

A Study to Check the Safety of Dexlansoprazole and Learn if it Can Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Children 2 to 11 Years Old

Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study

Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer

PHE885 CAR-T Therapy in Adult Participants With Relapsed and Refractory Multiple Myeloma

Single Arm, Open Label Trial With Iptacopan Treatment for 24 Weeks, in Patients on Stable Regimen of Anti-C5 Who Switch to Iptacopan.

Liver Cirrhosis Network Cohort Study